# Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus

> **NCT00453375** · PHASE1 · COMPLETED · sponsor: **Bayhill Therapeutics** · enrollment: 80 (actual)

## Conditions studied

- Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** BHT-3021
- **DRUG:** BHT-Placebo

## Key facts

- **NCT ID:** NCT00453375
- **Lead sponsor:** Bayhill Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453375, "Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00453375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*